These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36539016)

  • 1. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis.
    Marcovitch L; Focht G; Carmon N; Tersigni C; Ledder O; Lev-Tzion R; Church PC; Hyams JS; Baldassano RN; Bousvaros A; Mack DR; Hussey S; Otley A; Croft NM; Kappelman MD; Griffiths AM; Turner D
    Gastroenterology; 2023 Apr; 164(4):610-618.e4. PubMed ID: 36539016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC.
    Marcovitch L; Focht G; Horesh A; Shosberger A; Hyams J; Bousvaros A; Hale AE; Baldassano R; Otley A; Mack DR; Kappelman MD; Griffiths AM; Turner D
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):e35-e38. PubMed ID: 33720091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC).
    Marcovitch L; Nissan A; Mack D; Otley A; Hussey S; Mclean B; Lewis M; Croft N; Barakat FM; Griffiths AM; Turner D
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):373-377. PubMed ID: 27159210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
    Turner D; Otley AR; Mack D; Hyams J; de Bruijne J; Uusoue K; Walters TD; Zachos M; Mamula P; Beaton DE; Steinhart AH; Griffiths AM
    Gastroenterology; 2007 Aug; 133(2):423-32. PubMed ID: 17681163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis.
    Panes J; Otley A; Sanchez Gonzalez Y; Fitzgerald K; Zhou W; Ilo D; Brion T; Tahir MJ
    Dig Dis Sci; 2023 Jun; 68(6):2318-2332. PubMed ID: 36773193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
    Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of the pediatric ulcerative colitis activity index (PUCAI).
    Turner D; Hyams J; Markowitz J; Lerer T; Mack DR; Evans J; Pfefferkorn M; Rosh J; Kay M; Crandall W; Keljo D; Otley AR; Kugathasan S; Carvalho R; Oliva-Hemker M; Langton C; Mamula P; Bousvaros A; LeLeiko N; Griffiths AM;
    Inflamm Bowel Dis; 2009 Aug; 15(8):1218-23. PubMed ID: 19161178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis.
    Fabian O; Hradsky O; Lerchova T; Mikus F; Zamecnik J; Bronsky J
    Pathol Res Pract; 2019 Dec; 215(12):152689. PubMed ID: 31679791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
    Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of Endoscopic and Histologic Indices in Pediatric Ulcerative Colitis Using Centralized Review.
    Ricciuto A; Carman N; Benchimol EI; Siddiqui I; Putra J; Khanna R; Griffiths AM; Walters TD; Church PC
    Am J Gastroenterol; 2021 Oct; 116(10):2052-2059. PubMed ID: 34388139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.
    Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS
    Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity.
    Nakov RV; Nakov VN; Gerova VA; Tankova LT
    Folia Med (Plovdiv); 2019 Jun; 61(2):188-196. PubMed ID: 31301663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.